-
Something wrong with this record ?
Anterior chamber migration of dexamethasone intravitreal implant (Ozurdex®) through basal iridectomy (Ando) in a pseudophakic patient
A. Stepanov, M. Codenotti, A. Ramoni, M. Prati, N. Jiraskova, P. Rozsival, F. Bandello,
Language English Country Italy
Document type Case Reports, Journal Article
PubMed
26615950
DOI
10.5301/ejo.5000715
Knihovny.cz E-resources
- MeSH
- Dexamethasone administration & dosage MeSH
- Corneal Edema etiology MeSH
- Phacoemulsification MeSH
- Glucocorticoids administration & dosage MeSH
- Lens Implantation, Intraocular MeSH
- Drug Implants adverse effects MeSH
- Intravitreal Injections MeSH
- Iridectomy * MeSH
- Humans MeSH
- Macular Edema drug therapy MeSH
- Ocular Hypertension etiology MeSH
- Anterior Chamber pathology MeSH
- Pseudophakia etiology MeSH
- Prosthesis Failure etiology MeSH
- Aged MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
PURPOSE: Intravitreal implantation of dexamethasone implant (Ozurdex®) is being widely used for the treatment of macular edema (ME) after branch or central retinal vein occlusion, diabetic ME, and persistent ME associated with uveitis or Irvine-Gass syndrome. We describe a complication: migration of the dexamethasone implant into the anterior chamber through basal iridectomy (Ando) in a pseudophakic patient with development of corneal edema and secondary high intraocular pressure. METHODS: This is a case report of migration of Ozurdex® through basal iridectomy in a pseudophakic patient with iris claw lens. CONCLUSIONS: Pseudophakic patients, with a history of vitrectomy, even those with a basal iridectomy (Ando), are at high risk for migration of the Ozurdex® into the anterior chamber and development of corneal edema.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16027913
- 003
- CZ-PrNML
- 005
- 20161021122540.0
- 007
- ta
- 008
- 161005s2016 it f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5301/ejo.5000715 $2 doi
- 024 7_
- $a 10.5301/ejo.5000715 $2 doi
- 035 __
- $a (PubMed)26615950
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Stepanov, Alexandr $u Department of Ophthalmology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Hradec Kralove - Czech Republic.
- 245 10
- $a Anterior chamber migration of dexamethasone intravitreal implant (Ozurdex®) through basal iridectomy (Ando) in a pseudophakic patient / $c A. Stepanov, M. Codenotti, A. Ramoni, M. Prati, N. Jiraskova, P. Rozsival, F. Bandello,
- 520 9_
- $a PURPOSE: Intravitreal implantation of dexamethasone implant (Ozurdex®) is being widely used for the treatment of macular edema (ME) after branch or central retinal vein occlusion, diabetic ME, and persistent ME associated with uveitis or Irvine-Gass syndrome. We describe a complication: migration of the dexamethasone implant into the anterior chamber through basal iridectomy (Ando) in a pseudophakic patient with development of corneal edema and secondary high intraocular pressure. METHODS: This is a case report of migration of Ozurdex® through basal iridectomy in a pseudophakic patient with iris claw lens. CONCLUSIONS: Pseudophakic patients, with a history of vitrectomy, even those with a basal iridectomy (Ando), are at high risk for migration of the Ozurdex® into the anterior chamber and development of corneal edema.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a přední komora oční $x patologie $7 D000867
- 650 _2
- $a edém rohovky $x etiologie $7 D015715
- 650 _2
- $a dexamethason $x aplikace a dávkování $7 D003907
- 650 _2
- $a implantované léky $x škodlivé účinky $7 D004343
- 650 _2
- $a glukokortikoidy $x aplikace a dávkování $7 D005938
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a injekce intravitreální $7 D058449
- 650 12
- $a iridektomie $7 D032801
- 650 _2
- $a implantace nitrooční čočky $7 D019654
- 650 _2
- $a makulární edém $x farmakoterapie $7 D008269
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a oční hypertenze $x etiologie $7 D009798
- 650 _2
- $a fakoemulzifikace $7 D018918
- 650 _2
- $a selhání protézy $x etiologie $7 D011475
- 650 _2
- $a pseudofakie $x etiologie $7 D019591
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Codenotti, Marco $u Department of Ophthalmology, Faculty of Medicine University Vita-Salute San Raffaele in Milan and University Hospital San Raffaele in Milan, Milan - Italy.
- 700 1_
- $a Ramoni, Andrea $u Department of Ophthalmology, Faculty of Medicine University Vita-Salute San Raffaele in Milan and University Hospital San Raffaele in Milan, Milan - Italy.
- 700 1_
- $a Prati, Matteo $u Department of Ophthalmology, Faculty of Medicine University Vita-Salute San Raffaele in Milan and University Hospital San Raffaele in Milan, Milan - Italy.
- 700 1_
- $a Jiraskova, Nada $u Department of Ophthalmology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Hradec Kralove - Czech Republic.
- 700 1_
- $a Rozsival, Pavel $u Department of Ophthalmology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Hradec Kralove - Czech Republic.
- 700 1_
- $a Bandello, Francesco $u Department of Ophthalmology, Faculty of Medicine University Vita-Salute San Raffaele in Milan and University Hospital San Raffaele in Milan, Milan - Italy.
- 773 0_
- $w MED00180219 $t European journal of ophthalmology $x 1724-6016 $g Roč. 26, č. 3 (2016), s. e52-4
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26615950 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20161005 $b ABA008
- 991 __
- $a 20161021122949 $b ABA008
- 999 __
- $a ok $b bmc $g 1166227 $s 952543
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 26 $c 3 $d e52-4 $e 20160412 $i 1724-6016 $m European journal of ophthalmology $n Eur J Ophthalmol $x MED00180219
- LZP __
- $a Pubmed-20161005
